SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-24-000009
Filing Date
2024-05-09
Accepted
2024-05-09 07:52:53
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q carm-20240331.htm   iXBRL 10-Q 1293998
2 EX-31.1 carm-20240331xexx311.htm EX-31.1 10674
3 EX-31.2 carm-20240331xexx312.htm EX-31.2 10671
4 EX-32.1 carm-20240331xexx321.htm EX-32.1 4985
5 EX-32.2 carm-20240331xexx322.htm EX-32.2 4980
  Complete submission text file 0001485003-24-000009.txt   5446549

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT carm-20240331.xsd EX-101.SCH 45563
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT carm-20240331_cal.xml EX-101.CAL 59585
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT carm-20240331_def.xml EX-101.DEF 122882
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT carm-20240331_lab.xml EX-101.LAB 574497
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT carm-20240331_pre.xml EX-101.PRE 362150
72 EXTRACTED XBRL INSTANCE DOCUMENT carm-20240331_htm.xml XML 466294
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 24928651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)